Presymptomatic Awareness of BRCA1/BRCA2 Status and Outcomes in Women With Ovarian Cancer

被引：0
|
作者：
Armon, Shunit [1 ,2 ,3 ]
Hollander, Adi [3 ,4 ]
Segev, Yakir [5 ]
Rosengarten, Ora [2 ,3 ,6 ]
Tomer, Ariela [2 ,7 ]
Levy-Lahad, Ephrat [2 ,3 ,7 ]
Michaelson-Cohen, Rachel [1 ,2 ,3 ,7 ]
机构：
[1] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, 12 Shmuel Bait St,POB 3235, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Eisenberg R&D Author, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Hadassa Med Ctr, Dept Internal Med, Jerusalem, Israel
[5] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Carmel Med Ctr, Dept Gynecol Oncol, Haifa, Israel
[6] Shaare Zedek Med Ctr, Helmsley Canc Ctr, Med Ctr, Jerusalem, Israel
[7] Shaare Zedek Med Ctr, Fuld Family Med Genet Inst, Jerusalem, Israel
来源：
JAMA NETWORK OPEN | 2025年 / 8卷 / 03期
关键词：
D O I：
10.1001/jamanetworkopen.2025.1435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2
    Berchuck, A
    Carney, M
    Lancaster, JM
    Marks, J
    Futreal, AP
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1998, 41 (01): : 157 - 166
  • [42] Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer
    Jasiak, Anna
    Koczkowska, Magdalena
    Stukan, Maciej
    Wydra, Dariusz
    Biernat, Wojciech
    Izycka-Swieszewska, Ewa
    Buczkowski, Kamil
    Eccles, Michael R.
    Walker, Logan
    Wasag, Bartosz
    Ratajska, Magdalena
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2023, 130
  • [43] Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations
    Salyer, C.
    Kobelka, C.
    Barrie, A.
    Littell, R. D.
    Powell, B.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 206 - 207
  • [44] Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer
    Dombernowsky, Sarah Louise
    Weischer, Maren
    Freiberg, Jacob Johannes
    Bojesen, Stig Egil
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge Gronne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2339 - 2342
  • [45] Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2
    Minion, L.
    Dolinsky, J.
    Chao, E.
    Monk, B.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 383 - 384
  • [46] Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2
    Minion, Lindsey E.
    Dolinsky, Jill S.
    Chase, Dana M.
    Dunlop, Charles L.
    Chao, Elizabeth C.
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 86 - 92
  • [47] Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations
    Salyer, Chelsea
    Kobelka, Christine
    Barrie, Allison
    Weintraub, Miranda Ritterman
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2019, 154 (02) : 374 - 378
  • [48] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Metcalfe, KA
    Lynch, HT
    Ghadirian, P
    Tung, N
    Olivotto, IA
    Foulkes, WD
    Warner, E
    Olopade, O
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Narod, SA
    GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 222 - 226
  • [49] Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer
    Choi, Min Chul
    Jang, Ja-Hyun
    Jung, Sang Geun
    Park, Hyun
    Joo, Won Duk
    Song, Seung Hun
    Lee, Chan
    Lee, Je Ho
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (02) : 308 - 315
  • [50] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
    Petrucelli, Nancie
    Daly, Mary B.
    Feldman, Gerald L.
    GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
12345